Study

Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation. – Cost Effective Supplements

Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/19267708


Conclusion of this study

We demonstrate for the first time that TTA attenuates dyslipidaemia in patients with type 2 diabetes mellitus. These effects may occur through mechanisms involving PPAR-alpha and PPAR-delta activation, resulting in increased mitochondrial fatty acid oxidation.


Supplements analyzed in this study

TTA

Health conditions analyzed in this study

No health conditions information for this study.

Functions related to this study

Heart health


Slightly Positive
TTA


Body systems related to this study


Cardiovascular System
Scroll to top